Ali Ardakani

Founder & Managing Director

image

Novateur Advisor Since

2014

Field

Operations & Business Development

Specialties

Therapeutics, Medical Devices

"I have made it my life-long mission to ensure promising life science inventions get access to the best possible advice, are developed properly and reach patients worldwide."

Ali Ardakani
Founder & Managing Director

Ali Ardakani is a technical and entrepreneurial corporate development and operations biotech executive with 20 years of experience in managing life science projects and companies. His experience includes managing R&D projects in the areas of oncology, respiratory, infectious disease, CNS therapeutics and medical devices, as well as fundraising, licensing and M&A.

Ali is the Founder & Managing Director of Novateur Ventures. Until recently he was Senior Vice President Device & Business Development for Beyond Air (NASDAQ:XAIR), where he was involved with the company from early stage until Nasdaq public offering and several rounds of financing and licensing. He is the CEO and co-founder of Optigo Biotherapeutics, an ophthalmology R&D company, the Vice Chair of LifeSciences BC, and Entrepreneur in Residence at Innovation Boulevard and Calgary Innovation. He is also an Associate at Creative Destruction Labs. He was the Co-Founder and COO of Niiki Pharma, which was acquired in 2013 by Intezyne Technologies, of which he became the Vice President.

To date, Ali has taken several projects from concept to FDA approval, with two 510(k) approvals for medical devices and two FDA IND approvals. He has also worked on commercialization and pharma partnerships, as well as several global mergers and acquisitions.

Novateur
Newsletter

Subscribe to our newsletter for access to latest updates.

Resource
Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant
Events

Check out conferences and events we are attending!

Article
Features

Read articles by our team! Featured in BioteCanada Insights and Nature among others.